Related references
Note: Only part of the references are listed.Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
Marc Tardieu et al.
HUMAN GENE THERAPY (2014)
Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis
Hongyan Wang et al.
HUMAN MOLECULAR GENETICS (2014)
AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction
Lluis Samaranch et al.
MOLECULAR THERAPY (2014)
Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia
Morgane Perdomini et al.
NATURE MEDICINE (2014)
Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy
Judit Homs et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
S. J. Gray et al.
GENE THERAPY (2013)
Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions
Brittney L. Gurda et al.
JOURNAL OF VIROLOGY (2013)
Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune Responses
Agnieszka Ciesielska et al.
MOLECULAR THERAPY (2013)
Characterization of Naturally-Occurring Humoral Immunity to AAV in Sheep
Joseph Tellez et al.
PLOS ONE (2013)
Pre-existing Anti-Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
Vedell Louis Jeune et al.
HUMAN GENE THERAPY METHODS (2013)
Humoral immune response to AAV
Roberto Calcedo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Correction of Brain Oligodendrocytes by AAVrh.10 Intracerebral Gene Therapy in Metachromatic Leukodystrophy Mice
Francoise Piguet et al.
HUMAN GENE THERAPY (2012)
Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Lluis Samaranch et al.
HUMAN GENE THERAPY (2012)
Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV Antibodies
Christopher M. Treleaven et al.
MOLECULAR THERAPY (2012)
Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
Roberto Calcedo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration
J. Homs et al.
GENE THERAPY (2011)
Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
Melissa Bartel et al.
FRONTIERS IN MICROBIOLOGY (2011)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in Macaques
Lili Wang et al.
MOLECULAR THERAPY (2010)
Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins
Lauren E. Mays et al.
JOURNAL OF IMMUNOLOGY (2009)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector
Dolan Sondhi et al.
MOLECULAR THERAPY (2007)
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice
C. Riviere et al.
GENE THERAPY (2006)
Production of recombinant adeno-associated virus vectors
S Zolotukhin
HUMAN GENE THERAPY (2005)
Adeno-associated viruses undergo substantial evolution in primates during natural infections
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
